4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-031923
Chief Financial Officer bought 58,486 shares at an average $1.56 ($91,082)
From the SEC's structured data for this filing
Trades in this filing
Byam Rebecca · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-22 | Purchase : show line 1 in the form | +33,450 | $1.53 | $51,045 | 395,152 | D |
| 2023-05-23 | Purchase : show line 2 in the form | +5,036 | $1.57 | $7,887 | 400,188 | D |
| 2023-05-24 | Purchase : show line 3 in the form | +20,000 | $1.61 | $32,150 | 420,188 | D |
| Open-market purchases · 58,486 sh · avg $1.56 · $91,082 | ||||||
Loading xslF345X04/doc4.xml…